News and Announcements
Universal Biosensors Business Update; Fast Revenue Growth, Unique Patent Protected Technology & New Product Development
- Published June 21, 2016 12:30PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
21st June 2016, ASX Announcement
UBI: Investment Highlights:
- Targeting the large and growing Point-of-Care Diagnostics market
- Fast growth in revenues based on sale of disposable test strips
- Validating the technology through partnering deals with LifeScan and Siemens
- Unique patent protected technology with low cost manufacturing
- Driving growth beyond the existing product platform via new product development
Strong revenue performance with record Quarterly Service Fees achieved
- Blood glucose monitoring : QSF generated from OneTouch® Verio® were $4.9m in Q1’FY16 (up 68% compared to pcp)
- Blood coagulation monitoring : Xprecia Stride™ revenues were $183k in Q1’FY16 (up 154% compared to pcp)
- Total FY15 revenues improved 76% compared to pcp to $16.8m
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
